The effects of IFN-a, and 
Introduction
The phenomenon of postinflammatory skin pigmentation has been observed after various kinds of inflammatory skin disease, such as contact dermatitis and drug eruptions, although the mechanism(s) involved have not yet been explained. These diseases have a common histologic feature, the presence of inflammatory cells in the skin. Inflammatory cells are composed of lymphocytes, monocytes, and neutrophils, all of which produce IFN (1); in addition, lymphocytes infiltrating dysplastic nevi or melanoma lesions have been shown to produce IFN--y (2) . IFN have been reported to promote differentiation of various kinds of cells including myoblasts (3), histiocytic lymphoma cells (4) , and promyelocytic leukemia cells (5) . IFN have been reported in some studies to increase pigment production by melanoma cells (6) (7) (8) , but in others, to reduce it (9-1 1). The specific effects of IFN on melanogenesis thus have not yet been conclusively determined. Such studies suggest the possibility that IFN may elicit postinflammatory skin pigmentation by stimulating differentiation, and thus pigmentation, ofepidermal melanocytes. As a result, IFN have been used as potential antimelanoma agents in both animal models and clinical trials (12) (13) (14) .
Melanocytes are highly suitable models for studies of differentiation because melanin is a specific, readily visible, and identifiable product; the melanin pigment is produced by an enzyme termed tyrosinase (EC 1.14.18.1), which in turn can be quantitated rather easily. There are also many physiologically relevant agents that can induce differentiation in mammalian melanocytes in vivo and in vitro, including ultraviolet light and melanocyte-stimulating hormone (MSH).' Ideally, studies of differentiation would use normal melanocytes, but because these cells are sparse in mammals, and are very difficult if not impossible to culture in significant quantity, most studies on melanogenesis have relied on the use of murine melanomas, such as the B 16 , S9 1, and Harding-Passey. Those tumor lines were established > 30 yr ago, and thus there is a possibility that they have drifted significantly in phenotype, and no longer resemble the original pigmented tumors. Recently, the JB/MS melanoma was induced by carcinogens (15, 16) ; this tumor has now been adapted to tissue culture, and is a highly pigmented, relatively well-differentiated cell line, which has been proposed to serve as a more appropriate model for melanogenic and tumorigenic studies (15) (16) (17) (18) . In this report, JB/MS murine melanoma cells, as well as B16 and S91 cells, were used to investigate the effect of IFN on spontaneous and MSH-induced pigmentation. We have found that IFN-a, IFN-f3, and IFN-,y stimulate the expression of MSH receptors on the surface of melanoma cells; this enhanced binding capacity for MSH is followed by a significant synergistic stimulation of melanin production in the presence of MSH.
Methods
Materials. Natural murine IFN-a (1.4 X 106 IU/mg) and IFN-ft (5.6 observations). We have also used B 16 and S91 murine melanoma cells in some experiments; these were derived as previously noted (18) . DME and other tissue culture supplies were purchased from Gibco Laboratories (Grand Island, NY); our routine culture medium consisted of DME supplemented with 10% heat-inactivated, mycoplasma and virus-free FCS, 100 Ag/ml streptomycin, 100 U/ml penicillin, and 0.25 Ag/mi amphotericin-B, nonessential amino acids, and glutamine.
Unless otherwise noted, cells were harvested in exponential growth phase with trypsin/EDTA, and seeded at a concentration of 6 X 105 cells per 75-cm2 flask. The cells were maintained in a humidified incubator with 5% CO2 in air at 370C. 24 h later (day 0) the medium was removed and replaced with fresh medium containing IFN and/or MSH at the concentrations noted in the tables and figures; the appropriate medium was changed daily thereafter. MSH was routinely used (except as reported in Table IV ) at 2 X l0-7 M; this concentration has been shown to elicit maximal melanogenic response in murine melanoma cells, as previously reported (20) (21) (22) .
Determination of melanogenic activities. Melanogenic activities were measured by two radiometric assays as previously described ( 25 MCi/ml; New England Nuclear, Boston, MA) was used; after the incubation, 20 ,l were removed to filter discs and washed three times with 0.1 N HC1, two times with ethanol, and once with acetone. The discs were then dried and the radioactive, acid-insoluble melanin that had been formed was measured in a liquid scintillation counter. The data reported in the tables used a 16-h incubation, but in separate experiments, we have determined that rates of melanin production are linear throughout that time period. For analysis of tyrosinase activity, L-[3,5-3H]tyrosine (1 Ci/mmol, 250 MCi/ml; New England Nuclear) was used; after 1 h incubation, 20 Ml was removed and added to 980 Ml 0.1 N HCl with activated charcoal and Celite 545 in 12 X 75 mm tubes; after mixing for 1 h at 23°C, the tubes were centrifuged for 1,300 g for 10 min, and the [3H]water that had been formed as the result of tyrosine hydroxylation (which remains in the supernatant) was measured in a scintillation counter. Enzyme assays were carried out at least in triplicate and variability within the assays was always < ±15%; backgrounds were established by omitting either the enzyme sample or the cofactor. In related experiments (not shown), we have determined that neither MSH nor IFN has any effect on either ofthe two radiometric assays described above.
Flow cytometric analysis. Cells were harvested with 0.02% EDTA in HBSS and permeabilized with 70% ethanol for 30 min at 4°C; 106 cells were reacted with 50 Ml tyrosinase-specific MAb TMH-l for 1 hat 4°C; the specificity and reactivity of TMH-1 for mammalian tyrosinase has been previously reported (18, 25) . After the incubation, the cells were washed twice in HBSS The experimental protocol was as noted for Table I ; flasks of cells were harvested daily for determination of melanogenic activity, and remaining flasks were subcultured at day 4. Again, the appropriate media were changed daily; MSH was used at 2 X 10-7 M and IFN at I IU/ml. The data are expressed as in the predominant, enzymatically active form of tyrosinase (18, 25) . In Table III when MSH and IFN were used at the same time. Fig. 1 shows histograms of two of these cell populations; there was no difference in the shape and intensity of the specific histograms between control cells (Fig. 1A) and MSH-and IFN-'y treated cells (Fig. IB ). These data demonstrate that the action of MSH and IFN is not at the level of stimulating synthesis of tyrosinase, which agrees with our previous observations for response to MSH based on metabolic labeling and immunoprecipitation analyses (18) , and also with studies from other laboratories that used enzymatic criteria (20, 29) .
Synthesis and purification of biologically active iodinated MSH. We next examined the possibility that the stimulatory effects on melanin production elicited by IFN only in the presence of MSH resulted from increased hormonal stimulation due to modulation ofthe expression ofsurface MSH receptors. To perform such studies, an MSH receptor binding assay had to be optimized. In HPLC analysis of iodinated MSH (Fig. 2) , two radioactive peaks eluted after the residual unlabeled MSH (peaks II and III). The radioactive peak (peak II) that eluted immediately after the unlabeled MSH peak (peak I) was confirmed by amino acid analysis (not shown) to be monoiodinated MSH (peak II). The production of biologically active ['2511 ]-MSH has been a point of contention in the literature for some time (30, 31) ; it was suggested that the denaturation of the iodinated peptide resulted from the oxidation of methionine during the iodination procedure (32). The amino acid analyses demonstrated that reduction with DTT immediately after iodination preserves the methionine residue, and that the radioactive fraction eluting after the unlabeled MSH was authentic ['25I]-MSH (peak II). The results in Table IV demonstrate that the biological activity of the iodinated MSH was preserved; the labeled MSH is equivalent to the original unlabeled MSH (at many different concentrations) in the ability to stimulate melanin production, that is, tyrosinase activity.
MSH binding studies. In a time course study examining the rate ofbinding of labeled MSH to JB/MS cells (Fig. 3) (Fig. 5, inset) . The specific binding of the labeled hormone at the various concentrations was analyzed by Scatchard plots (Fig. 5) . The Scatchard analyses of IFNtreated and untreated cells fell on straight lines, which indicates that the receptors on both types of cells possess a single affinity for the ligand; IFN-a and IFN-'y gave essentially identical curves to the IFN-,B curve shown in Fig. 5 (data not shown). An average of three independent experiments yielded an equilibrium dissociation constant (Kd) of 2. 
Discussion
This study has shown that JB/MS melanoma cells are highly responsive to MSH: levels of melanin production were stimulated 25-fold within 4 d by the hormone (Table I) , and tyrosinase activity was increased > 6-fold (Table IV) . Treatment of JB/MS cells with IFN-a, IFN-fl, or IFN-y has no significant direct effect on melanogenic activity, but when JB/MS cells are cultured in IFN in the presence of MSH, melanogenic activity is synergistically stimulated relative to the level in cells treated with MSH alone. Examination of the kinetics of cellular responses to MSH alone, and to MSH with IFN, revealed that these effects occur rapidly, and that the effects of IFN are even more dramatic when the cells are subcultured (Table II) . MSH-and IFN-treated cells maintained their high levels of melanogenic activity after subculturing, which at times was seven to eightfold greater than cells maintained in MSH alone, which was in turn fivefold greater than the level in untreated cells.
Previous studies have reported that both human rIFN-a A/D (at 30-3,000 IU/ml) (10) stimulated melanin production in clones of B 16 murine melanoma cells, and L cell IFN had no antiproliferative effect on these cells. On the other hand, human rIFN-y (at 100 IU/ml) stimulated melanin production with a dose-dependent antiproliferative effect on the human melanoma cell line Colo 38 (6) . In yet another study (7), human rIFN-,3 (at 2,000 IU/ml) was reported to stimulate spontaneous melanin production in three out of four human melanoma cell lines, but had an antiproliferative effect on all four lines. The reasons behind such varied findings on the effects of IFN on pigmentation are not yet clear, but in light of the results presented in this paper, might reflect differences in (a) the reactivities of various cell lines to the different IFN, (b) the concentrations of IFN used, (c) the sensitivities of different cell lines to MSH, and/or (d) the densities of the cell populations examined.
In our study, cell density was a critical factor that affected the melanogenic activity of JB/MS melanoma cells (Table II) . Spontaneous melanin production was lowest when the cell extract was prepared from cells in the midexponential phase of growth (on days 2 and 3), and increased progressively thereafter. By day 5 in our experiments, when the cells were confluent, the melanogenic activity in untreated cells was seven times higher than on day 2. After subculturing of the cells, the melanogenic potential decreased again towards background levels. When the cells were treated with MSH, stimulation of melanin production was evident within 24 h (at which time it had doubled) and was highest on day 5. However, even when the cells were continually exposed to MSH, the melanogenic activity decreased rapidly after subculturing ofthe cells on day 5, and also reached its lowest point at day 7. From that point on, similar to the control cells, melanogenic activity increased again until day 9. An interesting contrast to this was the maintenance of high levels of melanin production after subculturing when the cells were kept in IFN-containing media. In light of the effect IFN has on the expression of surface MSH receptors, it would seem most likely that this effect is modulated through the continued expression of increased numbers of surface MSH receptors, even in rapidly proliferating cells. Although this has not yet been directly confirmed, the potential significance of this effect on mammalian melanogenesis in vivo, where melanocytes are constantly exposed to MSH and are slowly, but continually growing, should not be overlooked. Although an inhibitory effect of MSH on melanoma cell growth has been previously reported (21, 22) , such an effect was not seen within the 9- (36) , and to increase the expression of melanoma-associated antigens in human melanoma cell lines (6, 37) . On the other hand, the expression of some other melanoma-associated antigens was reduced after treatment with IFN-'y (6) . IFN (and especially IFN-'y) thus have been reported to modulate the expression of surface antigens. IFN treatment has also been shown to alter cell surface properties, for example, charge (38) , mobility of ligand receptors (39) , binding of lectins (40) , architecture (41) , and exposure ofgangliosides (42 
